BRODMANN, Marianne, Christian WISSGOTT, Andrew HOLDEN, Robert STAFFA, Thomas ZELLER, Thodur VASUDEVAN a Peter SCHNEIDER. Treatment of infrapopliteal post-PTA dissection with tack implants: 12-month results from the TOBA-BTK study. Catheterization and Cardiovascular Interventions. Hoboken: Wiley-Blackwell, 2018, roč. 92, č. 1, s. 96-105. ISSN 1522-1946. Dostupné z: https://dx.doi.org/10.1002/ccd.27568.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Treatment of infrapopliteal post-PTA dissection with tack implants: 12-month results from the TOBA-BTK study
Autoři BRODMANN, Marianne (40 Rakousko, garant), Christian WISSGOTT (276 Německo), Andrew HOLDEN (554 Nový Zéland), Robert STAFFA (203 Česká republika, domácí), Thomas ZELLER (276 Německo), Thodur VASUDEVAN (554 Nový Zéland) a Peter SCHNEIDER (840 Spojené státy).
Vydání Catheterization and Cardiovascular Interventions, Hoboken, Wiley-Blackwell, 2018, 1522-1946.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30201 Cardiac and Cardiovascular systems
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 2.551
Kód RIV RIV/00216224:14110/18:00104168
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1002/ccd.27568
UT WoS 000440646400023
Klíčová slova anglicky balloon angioplasty; critical limb ischemia; dissection; infrapopliteal arteries; peripheral artery disease; tibial artery
Štítky 14110121, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Soňa Böhmová, učo 232884. Změněno: 11. 2. 2019 15:42.
Anotace
Objectives: The Tack implant is designed for focal, minimal metal management of dissections. This study evaluated Tacks for treating postpercutaneous transluminal angioplasty (PTA) dissection in patients with below-the-knee (BTK) arterial occlusive disease. Background: PTA is the most commonly used endovascular treatment for patients with occlusive disease of the BTK vessels. Post-PTA dissection is a significant clinical problem that results in poor outcomes, but currently there are limited treatment options for managing dissections. Methods: This prospective, single-arm study evaluated patients with CLI and BTK lesions; 11.4% were Rutherford category (RC) 4 and 88.6% were RC 5. BTK occlusive disease was treated with standard PTA and post-PTA dissections were treated with Tack placement. The primary safety endpoint was a composite of major adverse limb events (MALE) and perioperative death (POD) at 30 days. Other endpoints included: device success; procedure success (vessel patency in the absence of MALE); freedom from clinically driven target lesion revascularization (CD-TLR); primary patency; and changes in RC. Data through 12 months are presented. Results: Thirty-two of 35 (91.4%) patients had post-PTA dissection and successful deployment of Tacks. Procedural success was achieved in 34/35 (97.1%) patients with no MALEs at 30 days. The 12-month patency rate was 78.4% by vessel, 77.4% by patient, and freedom from CD-TLR was 93.5%. Significant (P < .0001) improvement from baseline was observed in RC (75% of patients improved 4 or 5 steps). Conclusion: Tack implant treatment of post-PTA dissection was safe and effective for treatment of BTK dissections and resulted in reasonable 12-month patency and low rates of CD-TLR.
VytisknoutZobrazeno: 8. 9. 2024 20:56